Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-038521

Chief Executive Officer sold 3,000 shares at $50.02 ($150,060)

  • Chief Executive Officer acquired 3,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2017-06-06 Option exercise +1,100 $0.30 $333 1,100 D
Schenkein David P Chief Executive Officer 2017-06-06 Sale −1,100 $50.02 $55,022 0 D
Schenkein David P Chief Executive Officer 2017-06-07 Option exercise +1,900 $0.30 $575 1,900 D
Schenkein David P Chief Executive Officer 2017-06-07 Sale −1,900 $50.02 $95,038 0 D
Derivatives
Schenkein David P Chief Executive Officer 2017-06-06 Option exercise · Stock option (right to buy) −1,100 191,556 D
Schenkein David P Chief Executive Officer 2017-06-07 Option exercise · Stock option (right to buy) −1,900 189,656 D
Open-market sales · 3,000 sh · avg $50.02 · $150,060
Loading xslF345X03/doc4.xml…